Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Vonafexor (EYP001) | 1192171-69-9 | 99.4% | 489.76 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY10919750MG

Encompass_Preferred

Vonafexor (EYP001) is an orally active, non-steroidal, and selective FXR agonist. It significantly reduces HBsAg when combined with Peg-IFNα and can be used for anti-HBV research. In vitro, Vonafexor inhibits HBV replication in HepaRG cells, leading to significant reductions in HBV DNA, HBsAg, and HBeAg secretion. This effect is enhanced when combined with Entecavir or Tenofovir.

  • Orally active, non-steroidal, and selective FXR agonist.
  • Shows significant HBsAg reduction when combined with Peg-IFNα.
  • Can be used for anti-HBV research.
  • Inhibits HBV replication cycle in HepaRG cells.
  • Additive effects when combined with Entecavir or Tenofovir in inhibiting HBV DNA, HBsAg, and HBeAg secretion.

Catalog No. 50-003-45282


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.